Monitor next 13F filing to see if the selling trend continues; the cluster is small relative to market cap but reinforces a cautious stance given BVS's poor historical returns following similar signals.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $8.68entry
- T+1 · 5mo ago −1.96%α −2.50% · $8.51
- T+5 · 5mo ago −1.61%α −2.05% · $8.54
- T+20 · 4mo ago +40.78%α +38.89% · $12.22
- T+60 · 2mo ago +62.10%α +57.70% · $14.07
How similar events traded
Executive Summary
Three institutional sellers outnumber one buyer in Bioventus during Q3 2025, with a net reduction of approximately $1.9M. While D.E. Shaw doubled its small position, larger holders like Morgan Stanley cut 62.7% and Legal & General nearly exited. The cluster suggests waning institutional conviction following a period of weak stock performance.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$1.9M
▲ Buyers (1)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | DOUBLED | +168.2% | $1.3M | $797.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | TRIM | -62.7% | $4.3M | -$2.7M |
| Legal & General Group | NEAR_EXIT | -92.8% | $473.0K | -$438.3K |
| Barclays | TRIM | -25.1% | Not reported | Not reported |
Key Facts
- D.E. Shaw doubled its position to 188.9K shares, now worth $1.3M.
- Morgan Stanley trimmed 62.7% of its stake, reducing 409.2K shares.
- Legal & General nearly exited, selling 92.8% of its 71.4K shares.
- Barclays trimmed 25.1% of its 88.1K share position.
- Net aggregate selling of ~$1.9M across the cluster.
Financial Impact
Net institutional selling of approximately $1.9M (0.25% of market cap) during Q3 2025, dominated by three sellers reducing $2.7M vs one buyer adding $0.8M.
Risk Factors
- 13F data has a 45-day lag; positions may have already reversed.
- Cluster involves only 4 institutions, small sample size.
- Passive/asset manager selling may reflect index rebalancing rather than fundamental concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BVS-2025-Q3 |
Track record
18 reports on BVS
2 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +37.19% at T+60 after the May 8, 2026 report. 2 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $10.66 settles Feb 11
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $10.61 settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 5/10 No price data
- Nov 2, 202614d ago Press Release Neutral 5/10 Entry $10.95 settles Feb 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $14.65 settles Jan 26
- Aug 15, 202613w ago Institutional Cluster Mixed 5/10 Entry $13.88 to $11.02 ▼ −20.64% −17.88% vs SPY
- Aug 5, 202614w ago 8-K Bullish 7/10 No price data
- Aug 5, 202614w ago Press Release Bullish 7/10 Entry $15.26 to $14.86 ▼ −2.62% −2.81% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 4/10 Viewing Entry $8.68 to $14.07 ▼ −62.10% −57.70% vs SPY
- Jun 2, 202623w ago Press Release Bearish 6/10 Entry $8.11 to $13.97 ▼ −72.26% −71.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers